The overall 5-year survival rate for<unk>  is 91%, and the 10-year survival rate is 85%. By overall cancer staging into stages I to IV,<unk>  has a 5-year survival rate of 100% for stages I and II, 71% for stage III, and 50% for stage IV. Compared to other variants of<unk>  cell derived<unk>  cancer, bone metastases are commonly associated with<unk>  carcinoma. In the present study a high rate of bone metastases of 34% was observed.
Follicular thyroid cancer
Papillary thyroid cancer
Thyroid lymphoma
Medullary thyroid cancer
Anaplastic thyroid cancer
Thyroid adenoma
Radiation-induced thyroiditis
Poorly differentiated thyroid cancer